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of these processes and therefore represent potential 
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lntrolduction 
The outward world of animal cells is an intensely social and 
noisy milieu of intercellular chatter. Cells exchange a 
ceaseL:ss barrage of information, regulating one another’s 
activities to simultaneously maintain collective vitality and 
suppress anarchy. Despite the potential chaos of extracellu- 
lar life, an order and solidarity prevails that naturally evokes 
curiosity about how cells manage such precise and effective 
communication, particularly when one considers the intrin- 
sic dif?culties of interchange through a perilous, cluttered 
and unbounded space. Communication among cells pre- 
sents a challenging terrain, often dependent upon passive 
diffusi’ln of solutes towards their relevant targets, and, con- 
versely, requiring cell-bound receptors to efficiently 
capture cognate ligdnds on the fly. Other functions require 
cell-cell and cell-solute interactions to occur under blood 
flow and so demand mechanisms adapted to withstand 
shear rtress. How have cells evolved to accommodate the 
rigors of multicellularity? One necessary response has been 
the emergence of a versatile extracellular matrix (ECM) 
that provides both mechanical support and a porous 
medium for diffusion, as well as specific epitopes necessary 
for communication. This outer world presents a strikingly 
differe.lt landscape from the viscera of the cell in many 
ways, but most conspicuous is the preponderant assortment 
of carbohydrates that populate all corners of extracellular 
space. Cells present a diverse array of glycosylated lipids 
and proteins on their surface and in the surrounding 
expansl2. Collectively, these form a dense matrix, called the 
glycocalyx, that functions as the interface between a cell 
and the environment in which the cell negotiates its 
growth, survival and death. Carbohydrates are fundamental 
to virtually every aspect of extracellular traffic, fulfilling 
roles from purely structural to mediating the highly specific 
recognition events that underlie cell-cell communication. 
Nature has chosen well, as sugars are particularly well 
suited to mediate such an extraordinary variety of interac- 
tions: they are modular, akin to .nucleotides and amino 
acids, but, in addition, sugars can form branched structures 
with stereospecific linkages, features that confer exponen- 
tial capacity for structural diversity. 
Extracellular sugars are often elaborated with covalent 
modifications, such as sulfation, acetylation and phospho- 
rylation, that impart further structural variety. Among 
these modifications the most prevalent is sulfation. Once 
synthes zed along the secretory pathway, carbohydrate 
sulfate esters are found exclusively in the extracellular 
milieu, and carbohydrate sulfation could be among the 
mechanisms chosen by nature to address the challenges of 
RlO Chemistry & Biology 1999, Vol 6 No 1 
Figure 1 
Carbohydrate sulfation occurs Carbohydrate sulfoforms function 
along the secretory pathway on the cell surface and in the ECM 
. = Sulfate ester 
6 = Carbohydrate sulfoform on a glycolipid, glycoprotein or proteoglycan scaffold Extracellular space 
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Sulfated carbohydrates are found only on the 
cell surface and in the extracellular matrix 
(ECM) where they mediate intercellular 
communication. Sulfotransferases are resident 
Golgi enzymes and modify carbohydrate 
substrates, such as glycolipids and 
glycoproteins, along the secretory pathway. 
Sulfated products are secreted or presented 
on the cell surface. 
multicellular communication (Figure 1). Why so? Sulfate 
esters have many useful properties. Entirely anionic at 
physiological pH, they provide an electrostatic component 
to specific interactions without behaving as a base or 
nucleophile. In addition, sulfate esters are commonly 
found in clusters, a very important feature that underlies 
their versatility and unique function: mooring upon a car- 
bohydrate scaffold allows the spatial arrangement of two 
or more sulfate anions to contribute to overall ligand struc- 
ture, an efficient means of generating many unique struc- 
tures from a few modular features. 
In the past few years, enzymatic placement of sulfate 
esters onto carbohydrates has been recognized as a 
mechanism for generating unique ligands with specific 
receptor-binding activity [l]. Sulfated sugars mediate 
numerous highly specific molecular-recognition events, 
and, from a survey of the known sulfate-dependent inter- 
actions, two functional themes emerge. The first theme is 
the combinatorial biosynthesis of numerous carbohydrate 
sulfoforms within a glycosaminoglycan (GAG) chain that 
collectively represent a library of unique structures. (We 
use the term sulfoforms to denote sulfated carbohydrate 
structures that differ only in their pattern of sulfation.) 
Combinatorial sulfation is exemplified by heparan sulfate 
(HS), a GAG that displays extensive microheterogeneity 
of sulfoforms within one carbohydrate chain, thereby pre- 
senting a diverse array of unique motifs, each with the 
potential of binding a specific receptor (Figure 2 shows 
schematically the diversity of HS sulfoforms). The broad 
utility of such a versatile and adaptive scaffold is evident 
from the great variety of cell-surface interactions known to 
be mediated by a specific sulfoform of HS, including 
binding of growth factors, cytokines and pathogens. The 
second theme is the conversion of a common oligosaccha- 
ride into a unique ligand by sulfation (shown schemati- 
cally in Figure 3). For example, sulfation of a terminal 
N-acetylgalactosamine (GalNAc) residue on pituitary 
glycoprotein hormones regulates serum half-life by creat- 
ing a unique determinant that is selectively recognized by 
a sulfate-dependent hepatic receptor. These themes 
underlie a multitude of processes, from angiogenesis and 
tumor metastasis to leukocyte-endothelium adhesion at 
sites of inflammation. Accordingly, the carbohydrate sulfo- 
transferases that generate these epitopes have become the 
focus of intense interest, with the first molecular charac- 
terization reported only five years ago. The role of sulfo- 
transferases in modulating both normal and pathogenic 
processes has brought them to the foreground of research 
as novel therapeutic targets. Here we summarize the 
current knowledge of carbohydrate sulfotransferases and 
the biological functions of carbohydrate sulfoforms, high- 
lighting potential avenues for therapeutic intervention. 
Sulfotransferases and the chemistry of sulfate 
transfer 
Carbohydrate sulfotransferases are transmembrane, resi- 
dent enzymes of the Golgi network that recognize glycans 
attached to lipids and proteins passing through the secre- 
tory pathway (Figure 1 shows the biosynthesis of sulfated 
biopolymers in the secretory compartments and their 
delivery to the extracellular milieu). From current knowl- 
edge, the carbohydrate sulfotransferases appear distinct 
both structurally and in their biological function from the 
cytosolic sulfotransferases, a well-characterized family that 
recognizes small-molecule substrates such as steroids, 
flavonoids, neurotransmitters and phenols (reviewed in 
[2,3]). The roles of cytosolic sulfotransferases are primarily 
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Figure 2 
Proteoglycans are major constituents of the 
extracellular matrix and are characterized by 
pendant glycosaminoglycan (GAG) chains. 
The biosynthesis of GAG chains begins with a 
repeating disaccharide unit that undergoes 
extensive modification. The sulfotransferases 
modify the scaffold in a combinatorial manner 
to yield highly variable sulfoforms that display 
tissue-dependent and temporally regulated 
expression. 
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metabolic and include the inactivation of xenobiotics, 
steroid hormones and catecholamines, and the elimina- 
tion of catabolic end products. In contrast, the carbohy- 
drate sulfotransferases appear to play a fundamental role 
in extracellular signaling and adhesion by generating 
unique ligands from a carbohydrate scaffold. In this 
sense. the carbohydrate enzymes might be more similar 
in function to the tyrosine sulfotransferases [4--b], also 
resident in Golgi compartments, that modulate the acti- 
vity of both secreted and membrane-associated proteins 
through tyrosine sulfation [7-131 . 
All eukaryotic sulfotransferases catalyze the transfer of a 
sulfonyl group from an activated sulfate donor onto a 
hydroxyl group, or, less commonly, an amino group, of an 
acceptor molecule (Figure 4). The universal source of acti- 
vated sulfate for eukaryotic sulfotransferases is 3’-phospho- 
adenosine-.5’-phosphosulfate (PAPS) [14]. Biosynthesis of 
PAPS occurs in the cytosol by the sequential transformation 
of ATP by ATP sulfurylase and .4PS kinase. In mammals, 
both activities lie within a single, bifunctional cytoplasmic 
protein called PAPS synthetase; the human enzyme was 
cloned recently [IS]. PAPS traverses the lipid bilayer 
between the cytosol and the Golgi lumen via a PAPSPAP 
translocase (PAP, 3’-phosphoadenosine-5’-phosphate), a 
transmembrane antiport shuttle that has been purified and 
characterized [16]. 
The mechanism of sulfonyl transfer is unknown, although 
a handful of recent papers have begun to elucidate some 
of the finer details. An earlier report identified a lysine 
residue in the PAPS-binding site of a glycolipid sulfotrans- 
ferase (171. More recently, a conserved lysine residue has 
been shown to be essential for sulfotransferase activity of a 
heparan sulfate N-deacetylase/N-sulfotransferase [18]. 
Upon sequence alignment, this lysine residue also maps to 
the active-site lysine required for estrogen sulfotransferase 
activity. Although currently we have no three-dimensional 
structure of a carbohydrate sulfotransferase, two recently 
reported structures of estrogen sulfotransferase and PAP 
Figure 3 
A common carbohydrate epitope presented 
on a protein or a lipid scaffold can be 
converted into a unique ligand for a specific 
receptor by installation of a sulfate ester. 
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Figure 4 
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The general carbohydrate sulfotransferase reaction. The universal source of activated sulfate for mammalian sulfotransferases is 
3’-phosphoadenosine-5’-phosphosulfate (PAPS). 
co-crystallized with estrogen [19] or vanadate [ZO] provide 
clues about the active-site architecture. Coupled with 
mutational analysis of active-site residues, the latter study 
suggests an in-line sulfonyl transfer mechanism similar to 
the mechanism of phosphoryl transfer ascribed to many 
kinases [Zl]. The carbohydrate sulfotransferases share 
conserved amino-acid motifs observed in the PAPS 
binding site of estrogen sulfotransferase, and therefore 
these studies might be a relevant context in which to con- 
sider sulfonyl transfer to carbohydrate substrates. 
To date, 17 mammalian carbohydrate sulfotransferases 
have been cloned, and several more characterized and 
purified. The structural diversity of known sulfated 
glycans indicates that many more remain to be discovered. 
Very modest homology exists between cytosolic, tyrosine 
and carbohydrate sulfotransferases, evident only at the 
putative binding site for their common substrate PAPS 
[22]. Within the carbohydrate sulfotransferase family, 
initial examination suggests only modest homology among 
the enzymes that recognize different substrates. Although 
a few regions within the putative PAPS binding site are 
conserved among all the carbohydrate sulfotransferases, 
the remainder of most sulfotransferase sequences do not 
submit tidily to multiple sequence alignment. Among 
those enzymes with similar carbohydrate substrates, sig- 
nificant identity (SO-95%) is observed between homologs 
and between isoforms. As the rapid rate of cloning contin- 
ues, subclasses within the carbohydrate family will 
probably emerge that clarify the functional significance of 
disparate domains. 
The following discussion of individual carbohydrate sulfo- 
transferases begins with examples of the first paradigm out- 
lined above, in which a complement of enzymes generate a 
combinatorial array of sulfoforms along a GAG scaffold. 
This will be followed by an overview of the sulfotrans- 
ferases that operate on smaller, discrete oligosaccharide 
substrates, thereby converting them into specific ligands for 
cognate receptors. 
Glycosaminoglycans as scaffolds for 
combinatorial sulfation 
Heparan sulfate sulfotransferases 
Proteoglycans pervade the extracellular space and the cell 
surface in most tissues, and thereby constitute a dominant 
component of the medium in which cells function and 
thrive. Proteoglycans comprise extended protein back- 
bones bearing dense arrays of long, heterogeneous GAG 
chains that are akin to the bristles on a bottle brush, and, 
in many cases, these chains are sulfated. Table 1 summa- 
rizes the sulfated GAGS for which the associated sulfo- 
transferases have been characterized. 
Heparan sulfate (HS) and heparin are common components 
of a variety of proteoglycans that mediate numerous 
processes, including cell adhesion [23,24], activation of 
growth factors [Z-27], binding of cytokines and 
chemokines [28], and infection by bacteria [29,30] and 
viruses [31-X]. The biosynthesis of HS and heparin 
involves a multi-enzyme pathway within the secretory com- 
partment that combinatorially modifies the repeating disac- 
charide (GluA~1~4GlcNAc~1+4), (GluA, Glucuronic 
acid; GlcNAc, N-acetylglucosamine) to yield a variety of 
sulfoforms within long, highly variable anionic chains. Mod- 
ifications of HS and heparin include N-deacetylation/N-suI- 
fation of GlcNAc; epimerization of C.5 of GluA to give 
iduronic acid (IdoA); and sulfa&n of the 3- and h-hydroxyl 
groups of glucosamine-N-sulfate, and the Z-hydroxyl group 
of GluA or IdoA [36]. Although HS and heparin derive from 
the same repeating core disaccharide and subsequent trans- 
formations. they emerge as structurally distinct molecules 
with different expression levels across tissues, and, in 
general, heparin exhibits a highly restricted expression and 
a greater degree of sulfation than the more ubiquitous HS. 
The presentation of particular sulfoforms of I-IS and heparin 
appears to be regulated temporally and spatially, reflecting 
a finely tuned, tissue-specific expression of the sulfotrans- 
ferases that correlates with functionality (reviewed in [37]). 
The capacity of a cell to derive a variety of potential 
structures through the expression of a few key enzymes 
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Table 1 
Sulfoforms of glycosaminoglycans (GAGS) and the associated sulfotransftrrases. 
-___ __-- - 
l Heparan sulfate N-deacetylase/N-sulfotransferase 
l Human clones: [58,59] 
l Initiates modifical:ions of heparin and l-IS 
l Heparan sulfate glucosaminyl-3-0-sulfotransferase 
l Human and mouse clone: [41] 
l Important for antithrombin binding and clotting 
l Heparan sulfate iduronic acid-2-0-sulfotransferase 
* CHO cell clone: 1631; gene trap mutant mouse: 1431 
l Important for binding of HS to FGF-2 and embryogenesis 
l Heparan sulfate glucosaminyl-6-0-sulfotransferase 
l Human clone: [Sll 
l Important for activation of FGF-2 receptor by heparan sulfate-FGF-2 complex 
l Chondroitin sulfate GalNAc-6-0-sulfotransferase 
l Human clone: [651 
l Involved in development and maintenance of articular cartilage 
l Keratan sulfate Gal-6-0-sulfotransferase 
. Human clone: [79,60] 
l Found in several tissues including cartilage, cornea and brain 
represents a powerful and efficient means of modulating but also by the numerous functional modes of HS interac- 
the cell-surface chemistry. Accordingly, the orchestration of tions. For example, HS can harvest proteins from the ECM, 
the sulfotransferases that underlie HS and heparin architec- bringing ;:hem into the proximity of their cell-surface recep- 
ture is an elegant example of combinatorial biochemistry tors at a high local concentration [38], or HS can act as a co- 
and might provide targets for therapeutic intervention. receptor, forming an active complex with a protein ligand 
for receptor binding 1261. I-IS can inhibit protein activity by 
The versatility of HS heterogeneity is evident not only from binding nonproductively [39]. Furthermore, HS can acti- 
the diversity of proteins that bind a specific HS sulfoform vate enzymes through allosteric mechanisms [40]. In many 
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cases, the molecular details of these interactions reveal a 
recognition requirement for specific HS sulfoforms. For 
example, high..affinity binding of HS to antithrombin, an 
inhibitor of the clotting cascade, requires the presence of 
the rare epitopc 3-O-sulfated glucosamine. Consequently, 
the corresponding glucosaminyl-3-0-sulfot~allsferase could 
be an important regulator of blood clotting and a potential 
therapeutic target (see [41] and references therein). 
Another illustration is pro\-ided by the presence of iduronic 
acid-Z-O-sulfate within the context of a particular HS 
pentasaccharid,:. This specific sulfoform initially binds to 
fibroblast growth factor-Z (F(;l;-2) and subsequently forms 
a ternary complex \tith the FGF-2 receptor that stimulates 
endothelial cell growth associated with angiogenesis 
[26,42]. one strategy for blocking angiogenesis within 
tumor environments might therefore include disruption of 
iduronic acid-2-O-sulfr)trans~erase activity. Gene-trap 
mutation of HS 2-O-sulfotransferase revealed an essential 
role for this enzyme in mouse embryogenesis [43]. hlicc 
carrying this mutant sulfotransferase exhibited bilateral 
renal agenesis and defects in eye and skeletal formation, 
and died during the neonatal period shortly following birth. 
‘I‘hc sulfoforms generated by RS Z-0-sulfotransferase, 
therefore, are fundamental to normal development. 
In addition, sulfation of heparan sulfate on the h-position 
of glucosamine is required for the activation of the FGF 
receptor by the heparan-sulfate-FGF-2 complex [39] and 
therefore the corresponding glucosaminyl-60sulfotrans- 
ferase could bc yet another target for anti-angiogenic 
therapy. On the basis of these studies and others that map 
the binding of certain FGPs to specific HS sulfoforms, 
one may speculate that dynamic processes mediated by 
FGFs could be controlled by the underlying complement 
of enzymes that dictate HS sulfoform expression. 
Numerous other proteins are known to interact with HS 
or heparin. For example, a recent study investigated the 
sulfoforms of heparin and HS that bind to the basement 
membrane glycoprotein laminin-1, an interaction postu- 
lated to be inT,zol\;ed in tumor-host adhesion during 
metastasis. l’he HS fragments with high affinity for 
laminin-1 were found to be sulfate-rich and comprised 
six repeating disaccharide units of the structure 
((Z-SO,,)IdoA~l-~4(6-SO,)GlcNSO~~1~4) (441. impli- 
cating several enzymes, including the 2- and 6-O-sulfo- 
transferdses, acting in concert to promote the pathological 
interactions. Finally, platelet-derived growth factor-A 
(PDGF-A) binds the HS motif ((Z-SO,~)IdoAal~4(6- 
OS03)GlcNS0,~), an interaction that could be in\,olved in 
the regulation of secretion, storage and binding of 
PDGF-A to its receptor on smooth-muscle cells 14.51. 
It is apparent thal- dynamic changes in the density or struc- 
ture of HS sulfofomms accompany several normal and 
pathological transitions, although the molecular basis for 
many of these is not yet fully understood. For example, 
the characteristic presentation of HS sulfoforms during 
various neural developmental stages correlates to prefer- 
ential binding of different FGFs [46]. Also, differentiation 
of colon cells is accompanied by specific alterations in HS 
sulfoforms, and these changes affect binding of HS to 
platelet-derived growth factor [47]. Other processes in 
which HS could engender critical changes include athero- 
sclerosis [4X], aging [49] and Alzheimer’s disease [SO-X!]. 
Also, PL~no&m fallc@rum, the causative agent of 
malaria, uses both HS [53,54] and chondroitin sulfate 
[.54,X], another GAG, as cell-surface receptors. The inter- 
actions underlying these processes probably involve spe- 
cific HS sulfoforms and could represent opportunities for 
sulfotransferase-targeted therapy. 
Given the generality of HS and heparin in extracellular 
communication, the associated sulfotransferases represent 
a significant, albeit largely uncharted, class of modulatory 
enzymes. Table 1 includes a summary of the sulfotrans- 
ferases that participate in HS and heparin biosynthesis. 
The gateway to all modifications is N-deacetylation/ 
K-sulfation as this invariably precedes further enzymatic 
transformations. A single enzyme, N-deacetylase/N-suIfo- 
transferase (NDNST), catalyzes both reactions [56], and, 
by virtue of this regulatory role, is a principal determinant 
of the overall structure and sulfate density of HS and 
heparin. Several clones have been reported from mouse 
[57] and human [58,59] that indicate the enzyme has a 
broad tissue distribution. Given the primary role of this 
enzyme in regulating HS and heparin architecture, it is 
possible that other isoforms remain to be discovered. 
Several clones of the 0-sulfotransferase group have been 
reported. HS glucosaminyl-6-0-sulfotransferase [60] was 
originally purified from the conditioned media of CHO 
cells, and the sequence was used later to obtain the 
human clone from a cDN,4 library. HS iduronic acid-Z-O- 
sulfotransferase was purified [61] and cloned [62] from 
CHO cells. Finally, the HS glucosaminyl-30sulfotrans- 
ferase ~‘3s purified from a mouse cell line [63] and the 
sequence of the protein used to clone both the mouse and 
human genes [41]. 
Chondroitin GaINAc-6-0-sulfotransferase 
Chondroitin sulfate (CS) appears to have a dual role as 
both a structural component of the ECM and a mediator 
of signals through specific receptor-ligand interactions. 
The CS repeating unit is (GluA[31-+3GalNAcj31-+4),, and 
sulfation occurs predominantly on the 4- and 6-hydroxyl 
groups of GalNAc, and less commonly on the Z-hydroxyl 
group of GluA (Table 1). Comparable with the HS and 
heparin enzymes, distinct sulfotransferases are thought to 
operate in concert to generate a particular motif. Although 
microheterogeneity is not as extensive as on HS, a diverse 
range of rnotifs commonly exist within a single strand. 
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Recently, a human CS GalNAc-6-0-sulfotransferase clone 
was obtained [64] by homology to the clDNA for a previ- 
ously identified chick enzyme [65]. This sulfotransferase 
also recognizes galactose residues of the GAG keratan 
sulfate (KS), indicating a possible role in both CS and KS 
biosynthesis. A CS sulfotransferase specific to neural 
tissue was recently reported that shares 69% homolog) 
with the mammalian CS sulfotransferases [66]. The 
regioselectivity of this enzyme is not known. 
CS is a predominant component of cartilage and brain, 
where it serves in the maintenance of structural integrity. 
In addition, CS sulfoforms are dynamic and vary across 
tissues and developmental stages. CS in the brain ECM 
influences neural cell migration and axonal growth 
through interactions with other matrix proteins and cell- 
surface receptors, and therefore differential expression of 
CS sulfoforms could be important for neuronal develop- 
ment and maintenance (reviewed in [67]). Particular CS 
sulfoforms might promote neurite outgrowth [68], thereby 
playing a role in nav-igating neurons. In addition, develop- 
mental regulation of both the sulfation profile of CS 
chains and the relevant sulfotransferase activities in 
embryonic chicken brain vary markedly and predictably 
with development, and these alterations are precisely 
coordinated [69]. For example, in the latter study the ratio 
of chondroitin-6-sulfate to chondroitin-4-.sulfate and the 
ratio of their respective sulfotransferase activities were 
found to progressively decrease with development. These 
discoveries indicate that developmentally regulated 
expression of chondroitin sulfotransferases controls stage- 
specific presentation of CS structures. 
The participation of CS sulfoforms in disease is speculated 
from many examples in the literature. CS is a major compo- 
nent of joint cartilage, and, in the early stages of joint 
disease, changes have been observed in both the chain 
length and the pattern of sulfation in animal models and in 
humans [7O-731. These changes are thought to reflect part 
of the cellular response by chondrocytes to damage to the 
articular cartilage matrix. ‘l-he specificity of the changes 
shows that the biosynthesis of chondroitin sulfate is under 
tight cellular control in chondrocytes and suggests that 
selected patterns of sulfation within chains are expressed to 
suit different biological functions. The CS 6-O-sulfotrans- 
ferase appears essential for normal skeletal development 
and defects in h-0-sulfation are associated with genetic 
skeletal deformity [74,75]. Finally, PLa.stnodz’um fn/c$nmm 
uses certain CS chains, in addition to HS chains, as cell- 
surface receptors to gain entry into host cells [54,55.76]. 
Keratan sulfate Gal-6-0-sulfotransferase 
KS consists of the repeating disaccharide unit 
(Galpl-+4GlcNAcpl+3), which undergoes sulfa&n of the 
6-hydroxyl groups of both Gal and GlcIXAc (Table 1). KS is 
a principle component of cartilage and cornea1 tissue, and 
is also jound in brain but its precise roles have not been 
established, although the sulfdtion pattern varies during 
development [77] and in some disease states [78]. The 
human form of a sulfotransferase that generates Gal-6- 
sulfate on KS has been cloned [79.80]. It appears to be 
express-d in many tissues and heavily in brain and cornea, 
and is thought to play a critical role in cornea1 transparency. 
Some substrate overlap exists between the KS Gal-6-0- 
sulfotransferase (KSST) and the CS GalNAc-6-O-sulfo- 
transferase (CSST); for example, KSST accepts 
chondroitin as a substrate and CSST accepts keratan. 
(Indeec, the enzyme named the human KSST by Fukuta 
eta/. [79] is referred to as a CSST in *Mazany etaL [80] and 
in the NCR1 gene database. Its activity is sufficiently 
higher with KS than with CS, however, providing some 
confidence in its assignment as a KSST.) These enzymes 
could constitute a family of sulfotransferases characterized 
by a liberal substrate profile and might participate in the 
biosynthesis of both KS and CS proteoglycans. 
Sulfation converts small glycans into unique 
ligands 
Small, often branched glycans that bear one or two sulfate 
esters have been identified on a variety of glycolipids and 
glycoproteins. In several cases, the sulfate ester has been 
shown to convert the relatively common glycan, which 
does not have a specific receptor, into a unique ligand for a 
sulfate-dependent receptor. 
GlcNAc-6-0-sulfotransferases and modulation of the 
inflammatory response 
A landmark discovery in the emerging field of sulfotrans- 
ferase biology was the identification of sulfated oligosac- 
charidcz as key modulators of leukocyte-endothelial-cell 
interactions (811. I,-Selectin, :t constitutively expressed 
receptor on all circulating leukocytes, mediates the initial 
attachment of blood-borne leukocytes to endothelial cells 
of the b ood vessel walls during the constitutive process of 
lymphocyte homing to peripheral lymph nodes [82]. In 
addition, I.-selectin contributes to leukocyte adhesion and 
extravasation at sites of acute and chronic inflammation 
[X3]. ‘I’he endothelial-derived carbohydrate ligands that 
mediate lymphocyte adhesion in lymph nodes bear one or 
both of Gal-6-sulfate and GlcNAc-6-sulfate within sialyl 
Lewis x-capped oligosaccharides (1, Figure S and Table 2) 
184-871. These unusual sulfated motifs are thought to be 
expressed on endothelial cells at sites of chronic inflam- 
mation as well [8X]. The presence of sulfate esters is 
strictly required for functional I,-selectin binding; 
although the unsulfated glycan is found on a variety of 
cells, it does not function as an I,-selectin ligand. Enzy- 
matic sulfation during glycan biosynthesis therefore 
creates a critical recognition motif [89-911, implicating the 
corresponding sulfotransferases as key modulators of the 
inflammatory response and as novel targets for anti- 
inflammatory therapy. 
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Figure 5 - 
I Sulfoform of Sialvl Lewis x 
L-Selectin 
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The endothelial ligand for the leukocyte 
adhesion molecule L-selectin, expressed on 
circulating leukocytes, is a sulfoform of sialyl 
Lewis x. Sulfation at the 6-position of Gal 
and/or GlcNAc converts the underlying glycan 
to a functional, high-affinity ligand for 
L-selectin, initiating the extravasation of 
leukocytes into the surrounding tissue. The 
corresponding endothelial sulfotransferases 
might be novel anti-inflammatory targets. 
This discovery has prompted several groups to pursue the 
molecular identification of the endothelial sulfotrans- 
ferases. A recent report characterized a GlcNAc-h-O-sulfo- 
transferase activity from porcine peripheral lymph nodes 
that was highly restricted in its expression to endothelial 
cells within lymphoid tissue, suggesting a role in the 
biosynthesis olf L-selectin ligands [92]. The enzyme 
required a terminal GlcNAc residue as a component of a 
synthetic oligosaccharide substrate, and was impeded by a 
terminal pl+4Gal attached to the’ GlcNAc residue. A 
candidate human GlcNAc-60sulfotransferase has now 
been cloned that shares the same restricted tissue distrib- 
ution and substrate specificity as the porcine enzyme [93]. 
A second candidate GlcNAc-60sulfotransferase, cloned 
from both murine and human sources, was reported 
recently [94,95]. This enzyme shares some features with 
the lymph node GlcNAc-6-0-sulfotransferase, such as 
preference for a terminal GIcNAc residue and expression 
in lymph node endothelial cells, although it is also 
expressed in many other tissues, including tumors. This 
latter enzyme i:s also capable of generating GlcNAc-h-sul- 
fated sialyl Lewis x when transfected into heterologous cell 
lines. The potential significance of these GlcNAc-h-O-sul- 
fotransferases in lymphocyte homing and in the inflamma- 
tory response, and the regulation of their expression, are 
subjects of significant current interest. Given the funda- 
mental role of II in mediating leukocyte adhesion, and its 
highly restricted tissue distribution, it is possible that a 
specific Gal-6-0-sulfotransferase is yet to be discovered. 
The L-selectin-ligand interaction is not alone as a sulfate- 
dependent mediator of leukocyte-endothelial cell adhe- 
sion. Recently, the leukocyte adhesion molecule CD44 
was shown to be sulfated on unidentified carbohydrate 
chains in response to trleatment of the cells with tumor 
necrosis factor a [96]. Sulfation conferred binding activity 
to hyaluronic acid, an extracellular matrix component on 
cognate endothelial cells. In yet a third example, 
P-select& induced on endothelial cells in response to pro- 
inflammatory signals, interacts with a leukocyte-associated 
glycoprotein termed PSGL-1 that is sulfated on tyrosine 
residues. In this case, tyrosine sulfate is critical for high- 
affinity binding [7,8,97]. The striking sirnilarity of these 
cell-adhesion events in the vascular compartment with 
respect to sulfate-dependency leads to an intriguing qucs- 
tion: is sulfate a preferred signal for interactions that must 
occur under conditions of blood flow? The chemical prop- 
erties of sulfate might contribute to the necessary kinetic 
and thermodynamic parameters for these events to take 
place under shear stress [%l]. 
GaINAc-4-0-sulfotransferase and regulation of 
glycoprotein hormone activity 
Another unusual sulfated epitope. (4-SO,)GalNAcPl+ 
4GlcNAcPl+ZMana-OR, is found on several glycoprotein 
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Table 2 ~-~ 
Sulfoforms of small glycans and the associated sulfotransferases. --- 
l GlcNAc- and Gal-6-0-sulfotransferases 
l Candidate GlcNAc-6-0-sulfotransferase clones: [93-951 
l KS Gal-6-3-sulfotranserases (Table 1) may participate in 
the biosynthesis 
l Epitope found on specialized lymph node endothelial cells and 
possibly 01 endothelium in chronically inflamed tissues; this 
sulfoform is a ligand for the leukocyte adhesion molecule 
HO 
l GalNAc-4,Osulfotransferase 
l Characterization/purification: [102,103] 
l Epitope found on pituitary glycoprotein hormones; regulates serum 
half-life by binding to a hepatic receptor 
l Glucuronic acid-3-0-sulfotransferase 
l Rat and human clones: [120,121 I 
l Defining component of the HNK-1 epitope; found on glycoproteins 
and glycolipids of the nervous system and in the retina; proposed 
role in neural cell adhesion 
l Galactosylceramide-3-O-sulfotransferase 
l Human cloie: [123] 
l Epitope found on myelin, spermatozoa, kidney and small intestine; 
interacts w th ECM proteins, cell adhesion molecules and serum 
factors 
NH 
NHAc NHAc 
l NodH sulfo:ransferase 
l A component of the Rh~~obium nodulation gene cluster: [127,128] 
l Sulfation of Nod factors confers plant host specificity; epitope binds 
a specific receptor on plant root hairs 
hormones produced by the pituitary gland such as lutropin the epitcpe and remove the hormones from the medium 
and thyrotropin (Table 2). The presence of sulfate on the [99-1011. The corresponding GalNAc-40-sulfotransferase 
glycan reduces the serum half-life of the hormones, therefore plays a fundamental role in regulating hormone 
thereby regulating their bioactivity [98]. The effect of sul- homeostEsis by creating a unique ligand for the clearance 
fation on serum half-life can be accounted for by sulfate- receptors. Indeed, this provides an additional level of 
dependent clearance receptors on liver cells that recognize control over hormone activity beyond simply modulating 
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the rate of production by the pituitary gland. The enzyme 
responsible for the modification has not yet been identi- 
fied at the molecular level, although the protein has been 
purified from bovine submaxillary gland and extensively 
characterized [ 102,103]. 
Glucuronic acid-SO-sulfotransferase and the HNK-1 epitope 
The sulfated oligosaccharide epitope (3-S03)GluAfi1-+ 
3Gal~1-+4GlcNAc (Table 2) is a highly restricted struc- 
ture that was first identified on human natural killer 
(HNK) cells by a specific monoclonal antibody termed 
HNK-1 [104107]. Subsequent research has shown this 
structure to be otherwise confined to the nervous system 
[108] and eye [109] where it is carried by a variety of cell- 
surface glycolipids and glycoproteins involved in adhesion 
and recognition, including the neural cell-adhesion mole- 
cule (NCAM), Ll, PO, proteoglycans, tenascin and inte- 
grins [llO,lll]. Although the function of this epitope on 
HNK cells remains unknown, intense interest in the 
HNK-1 carbohydrate antigen arose from the discover! 
that IgM from humans with peripheral demyelinating 
neuropathies recognize this sulfated carbohydrate in a 
sulfate-dependent manner [ 1 Oh. 112-I 141. The role of the 
HNK-1 epitope in human demyelinating diseases is not 
fully understood, but several lines of evidence support its 
participation in pathology [10X]. 
The normal functions of the HNK-1 carbohydrate antigen 
include an intimate role in the development and mainte- 
nance of nervous-system architecture. In particular, the 
exquisitely precise cell-adhesion and recognition processes 
that underlie the formation and maintenance of myelin, 
neurite outgrowth and axonal guidance are mediated, in 
part, by the HNK-1 epitope [108,111]. E-INK-l-bearing 
molecules have differential expression patterns over time 
and neural cell type [115-l 171. In addition, sulfation occurs 
at the onset of myelination and regeneration. but ceases 
after development and does not occur when injured nerves 
cannot remyelinate [118]. Many of these functions have 
been shown to be dependent on the presence of the sulfate 
ester within the epitope. For example, the binding of the 
HNK-1 carbohydrate epitope to laminin is sulfate depen- 
dent [I 191. Furthermore, the interactions between HNK-1 
and laminin halve been shown to mediate neural cell migra- 
tion and outgrowth, processes that also require the sulfated 
glucuronic acid moiety [119]. ‘4ccordingly. the GluA-3-O- 
sulfotransferase that generates the epitope plays a central 
role in the development and maintenance of the nervous 
system. Two groups reported recently the GluA-3-O-sulfo- 
transferase clone [ 120,lZ 11 paving the way for the essential 
studies needed to establish the function of the HNK-1 
carbohydrate in normal and pathological cell adhesion. 
Galactose ceramide 3-O sulfotransferase 
The glycolipid (3-SO,3)-galactosylceramide (Table 2) com- 
prises 6% of the lipid in brain. is primarily localized to the 
myelin sheath, and is also abundant in spermatozoa, 
kidney and small intestine (reviewed in [122]). Sulfogly- 
colipids as a class are implicated in many biological func- 
tions through their specific interactions with von 
Willebrand factor, amphoterin, human growth factor, 
laminin and thrombospondin. The human galactosyl- 
ceramide-3-0-sulfotransferase has been purified and 
cloned [ 1231, revealing little homology to any other sulfo- 
transferase, including the GluA-3-C)-sulfotransferase. 
Certain renal-cancer cell lines express abnormally high 
levels of this enzyme [l&J], although the significance of 
this observation has not yet been ascertained. 
Rhizobial sulfotransferases and the host specificity of root 
nodulation factors 
Carbohydrate sulfation might be a universal mechanism 
for cell-cell interchange that extends to unicellular organ- 
isms as well. For example, R/&o& secrete specific 
lipooligosaccharide signals called nodulation or ‘hod 
factors that are required for root nodulation and infection 
of legumes [12.5]. In response. the host plant will generate 
nodules, organs in which the bacteria live and convert 
nitrogen to ammonia. Symbiosis is restricted to particular 
combinations of legume hosts and bacterial strains, and 
species specificity of host-plant pairing is derived from 
the interaction of a bact’erium’s Nod factor with a specific 
receptor on host plant root hairs. The nitrogen-fixing bac- 
terium R/zizohiu meHot/ secretes a sulfated lipochitote- 
traose (Table 2) to initiate symbiosis with the host plant 
alfalfa [126]. In this case, sulfate on the reducing-terminal 
GlcNAc residue is the sn-uctural determinant that confers 
host specificity. Without sulbte, the factor elicits symbio- 
sis with vetch rather than alfalfa. The GlcNAc-&O-sulfo- 
transfer.lse responsible for this modification, the product 
of the nodH gene, has been fully characterized [127]. 
Other strains of R/&oh~~ secrete variations of this sulfated 
lipooligosaccharide that confer specificity to different host 
species. A related strain, R. tropiu’, expresses a closely 
related enzyme. sharing 69% identity with R. m/i/oti 
NodH [ 1281. The sulfate group is a requirement for infec- 
tion of the host Leucuent~ plants 11291, although R. tropici 
produces a mixture of sulfated and non-sulfated Xod 
factors, perhaps allowing for symbiosis with a range of host 
plants. A solitary fucose sulfotransferase h:ls been reported 
in another strain, Rhizohi,vm sp. NGK2.34. Structural analy- 
sis of isolated Nod factors identified both 3- and 4-O-sul- 
fated fucose residues 11301, modifications that might 
modulate host specificity [131,132]. 
Perhaps it is not a coincidence that bacteria use sulfated 
carbohydrates for intercellular communication and sym- 
biosis. Indeed, the exclusive role of mammalian carbohy- 
drate sulfoforms in cell-cell communication might be the 
evolutionary consequence of single-cell organisms signal- 
ing for interaction with the more complex world. 
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Conclusions 
How we come to fathom intercellular communication and 
multicellular function rests, in part, upon our understand- 
ing of the sulfotransferases and how they shape and direct 
extracellular chemistry. In contrast to the growing body of 
knowledge about the biology of carbohydrate sulfoforms, 
there is a paucity of chemical information regarding 
sulfate-dependent recognition events and the catalytic 
mechanisms of carbohydrate sulfotransferases. There are 
no three-dimensional structures of carbohydrate sulfo- 
transferases, few mechanistic studies and no inhibitor of 
any member from this class of enzymes has been reported. 
The medicinal chemistry of carbohydrate sulfotransferases 
is therefore a wide-open frontier. More fundamentally, 
why has nature chosen sulfated oligosaccharides to 
conduct extracellular information? As the chemical proper- 
ties of sulfate-dependent binding events are revealed, this 
and other questions can be answered. 
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